MLTX icon

MoonLake Immunotherapeutics
MLTX

Overview Fund Trends Analyst Outlook Journalist POV

46 hedge funds and large institutions have $122M invested in MoonLake Immunotherapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11.5M
2
+$8.53M
3
+$8.53M
4
RI
RTW Investments
New York
+$8.53M
5
RCM
RA Capital Management
Massachusetts
+$7.96M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$11.5M
2
$8.53M
3
$8.53M
4
$8.53M
5
$7.96M
6
$7.58M
7
$7.44M
8
$5.68M
9
$4.74M
10
$4.55M
11
$4.55M
12
$4.55M
13
$3.64M
14
$2.84M
15
$2.84M
16
$2.84M
17
$2.71M
18
$2.44M
19
$2.27M
20
$2.27M
21
$2.27M
22
$1.76M
23
$1.71M
24
$1.71M
25
$1.69M
1
2